Buscar
OPKO Health Inc
OPKAñadir a la lista de seguimiento
1.650USD
+0.410+33.06%
Cierre 07-28 16:00（ET）Cotizaciones retrasadas 15 min
1.25BCap. mercado
PérdidaP/E TTM
Más Datos de OPKO Health Inc Compañía
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Información de OPKO Health Inc
Símbolo de cotizaciónOPK
Nombre de la empresaOPKO Health Inc
Fecha de salida a bolsaNov 02, 1995
Director ejecutivoCruz (Tony F)
Número de empleados2997
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 02
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónOPK
Fecha de salida a bolsaNov 02, 1995
Director ejecutivoCruz (Tony F)
Ejecutivos de OPKO Health Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
--
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Independent Director
Independent Director
66.49K
--
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
--
--
Dr. Phillip Frost ,M.D.
Dr. Phillip Frost ,M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Jane H. Hsiao, Ph.D.
Dr. Jane H. Hsiao, Ph.D.
Vice Chairman of the Board, Chief Technical Officer
Vice Chairman of the Board, Chief Technical Officer
--
--
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Executive Vice President - Administration, Director
Executive Vice President - Administration, Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Dr. Charles W. Bishop, Ph.D.
Dr. Charles W. Bishop, Ph.D.
Chief Executive Officer of OPKO Renal
Chief Executive Officer of OPKO Renal
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Adam E. Logal
Mr. Adam E. Logal
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Treasurer
179.16K
--
Dr. Richard M. Krasno, Ph.D.
Dr. Richard M. Krasno, Ph.D.
Independent Director
Independent Director
103.33K
--
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
President, Vice Chairman of the Board
President, Vice Chairman of the Board
89.60K
--
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Dr. Alice Lin-Tsing Yu, M.D., Ph.D.
Independent Director
Independent Director
66.49K
--
Mr. John A. Paganelli
Mr. John A. Paganelli
Independent Director
Independent Director
--
--
Dr. Phillip Frost ,M.D.
Dr. Phillip Frost ,M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de OPKO Health Inc?
Los cinco principales accionistas de OPKO Health Inc son: Mr. Adam E. Logal
¿Cuántas instituciones poseen acciones de OPKO Health Inc (OPK)?
A fecha de 2026Q1, 451 instituciones poseen acciones de OPKO Health Inc, con un valor de mercado combinado de aproximadamente 236.82M, lo que representa el 31.36% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -9382421.00.
¿Cuál es la mayor fuente de ganancias de OPKO Health Inc?
El 2026Q1, el segmento empresarial Health Insurers generó la ganancia más alta para OPKO Health Inc, ascendiendo a 213.60M y representando el 57.69% de la ganancia total.